
SF Healthcare Week: Baird Senior Analyst Brian Skorney comments on Monday's conference news and highlights his top picks ahead for 2026
BiotechTV - News
00:00
Sarepta: Ongoing Drama and Transition
Brad asks about Sarepta; Brian reviews gene therapy uptake, safety monitoring, and Sarepta's RNA strategy.
Play episode from 09:20
Transcript


